After being the target of much investor attention amid the COVID-19 pandemic, many investors have rotated out of the pricey pharmaceutical sector over the past… Read More »These 3 Pharmaceutical Stocks Look Significantly Undervalued
Due in part to the American Society of Clinical Oncology’s big cancer conference, June is often a popular month for M&A activity in the biotech… Read More »Why Biotech M&A Activity Could Heat Up In June – And Some Potential Acquisition Targets
“While the start of the calendar year is often prime time for U.S. Food and Drug Administration (FDA) events and trial data to be released,… Read More »With Major Catalysts This Summer, These 8 Biotech Stocks Could Heat Up
Today’s article highlights four small biotech stocks with the potential to go from little players to leaders in the space in relatively short order, including… Read More »4 Small Biotech Stocks With The Potential To Go From Little Players To Leaders
When it comes to biotech plays, the author of today’s article advises that there are two investors should know: “The first is to buy stock… Read More »2 Biotech Plays To Know – And 1 Stock For Each Play Right Now
“Remember, no other sector sees stocks move 50% or even more than 100% in a day on a takeover announcement,” notes the author of today’s… Read More »How To Choose Which Biotech Stocks To Pull The Trigger On
As biotech stocks experience a broad correction, the analyst cited in today’s article sees “a number of compelling values” in the space. In particular, he… Read More »Looking For Wins In The Biotech Space
The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
When it comes to the best way to gauge biotech stocks ahead of big catalysts, the author of today’s article recommends turning to Wall Street… Read More »Catalysts & Analysts: Why These 2 Biotech Stocks Have Impressive Upside Potential
Regardless of whether the COVID-19 pandemic abates this year or not, the telehealth trend is expected to continue – and that could help one of… Read More »A Return To Normal Or More ‘New Normal’, 2 Healthcare Stocks That Could Soar This Year